M.D. Anderson Cancer Center
To find out whether the BIA test can help identify participants with IBC who are at risk for developing lymphedema.
Primary Objectives The primary objective is to reliably describe risk factors for development of BCRL in IBC using BIA.
Eligibility Criteria All women≥18 years old with newly diagnosed inflammatory breast cancer without prior breast/axillary surgery who are eligible for standard of care (NST, MRM, and radiation therapy). Exclusion Criteria Prior breast/axillary surgery. Participants with pacemakers or other implanted electronic medical devices. Participants with implanted metallic material. All vulnerable populations, including children, pregnant women, and cognitively impaired adult
all patients will start/continue neoadjuvant systemic therapy
Verify or correct the compensation shown for this listing.